Income Tax |
3 Months Ended |
|---|---|
Mar. 31, 2026 | |
| Income Tax [Abstract] | |
| INCOME TAX | NOTE 13 – INCOME TAX
The Company accounts for income taxes in accordance with ASC 740, Income Taxes. For , adjusted for discrete items occurring during the period.
For the three months ended March 31, 2026 and 2025, the Company recorded no income tax expense or benefit. The Company incurred losses before income taxes of $1,077,582 and $1,088,998 for the three months ended March 31, 2026 and 2025, respectively. The expected tax benefit generated from these losses was fully offset by a valuation allowance against deferred tax assets, resulting in an effective tax rate of 0.0% for each period. The Company maintains a full valuation allowance against its deferred tax assets, which consist primarily of net operating loss carryforwards and other temporary differences, because management believes it is more likely than not that the deferred tax assets will not be realized. Management evaluates the realizability of deferred tax assets each reporting period based on available evidence, including cumulative losses, projected future taxable income, and tax-planning strategies. There were no material changes to the Company’s deferred tax assets or valuation allowance during the three months ended March 31, 2026.
The Company’s net operating loss carryforwards may be subject to limitation under Section 382 of the Internal Revenue Code in the event of an ownership change. The Company has not recorded any liability for uncertain tax positions and is not currently under examination by taxing authorities. |